Alumis Inc. SEC filings ALMS
Alumis Inc. has 247 filings in SEC EDGAR's recent list, going back to Feb 25, 2021. Its latest annual report, Form ARS, was filed on May 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 1, 2026 | Sep 1, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Other events
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| ARS | Annual report to shareholders | May 18, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | May 18, 2026 | — |
| DEF 14A | Proxy statement | May 18, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Other events
|
Mar 30, 2026 | Mar 28, 2026 |
| S-3ASR | Automatic shelf registration | Mar 19, 2026 | — |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2026 | Mar 19, 2026 |
| S-8 | Employee stock plan registration | Jan 30, 2026 | — |
| 8-K |
Current report
Results of operations, Other events
|
Jan 9, 2026 | Jan 7, 2026 |
| 424B5 | Prospectus supplement | Jan 8, 2026 | — |
| 424B5 | Prospectus supplement | Jan 6, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Other events
|
Jan 2, 2026 | Jan 2, 2026 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| EFFECT | Filing | Aug 19, 2025 | — |
| CORRESP | Letter to the SEC | Aug 15, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Aug 4, 2025 | Jul 30, 2025 |
| UPLOAD | Letter from the SEC | Jul 9, 2025 | — |
| S-3 | Shelf registration | Jul 3, 2025 | — |
| 8-K/A | Amended current report | Jun 30, 2025 | May 21, 2025 |
| ARS | Annual report to shareholders | Jun 16, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Jun 16, 2025 | — |
| DEF 14A | Proxy statement | Jun 16, 2025 | Jul 30, 2025 |
| S-8 | Employee stock plan registration | Jun 10, 2025 | — |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Other events
|
May 21, 2025 | May 21, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 425 | Filing | Apr 29, 2025 | — |
| EFFECT | Filing | Apr 23, 2025 | — |
| 424B3 | Prospectus | Apr 23, 2025 | — |
| 10-K/A | Amended annual report | Apr 23, 2025 | Dec 31, 2024 |
| CORRESP | Letter to the SEC | Apr 22, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2025 | — |
| S-4 | Registration for a merger or exchange | Apr 21, 2025 | — |
| 425 | Filing | Apr 21, 2025 | — |
| 425 | Filing | Apr 21, 2025 | — |
| 425 | Filing | Apr 21, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 21, 2025 | Apr 20, 2025 |
| EFFECT | Filing | Apr 4, 2025 | — |
| 425 | Filing | Apr 4, 2025 | — |
| 424B3 | Prospectus | Apr 4, 2025 | — |
| CORRESP | Letter to the SEC | Apr 2, 2025 | — |
| S-4/A | Filing | Apr 2, 2025 | — |
| S-4 | Registration for a merger or exchange | Mar 27, 2025 | — |
| 425 | Filing | Mar 25, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| S-8 | Employee stock plan registration | Mar 19, 2025 | — |
| 425 | Filing | Mar 19, 2025 | — |
| 10-K | Annual report | Mar 19, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| 425 | Filing | Mar 18, 2025 | — |
| 425 | Filing | Mar 11, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 10, 2025 | Mar 8, 2025 |
| 425 | Filing | Mar 6, 2025 | — |
| 425 | Filing | Mar 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2025 | Feb 18, 2025 |
| UPLOAD | Letter from the SEC | Feb 19, 2025 | — |
| DRS | Filing | Feb 14, 2025 | — |
| 425 | Filing | Feb 7, 2025 | — |
| 425 | Filing | Feb 7, 2025 | — |
| 425 | Filing | Feb 6, 2025 | — |
| 425 | Filing | Feb 6, 2025 | — |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
|
Feb 6, 2025 | Feb 6, 2025 |
| UPLOAD | Letter from the SEC | Dec 3, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 25, 2024 | Nov 22, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| D | Filing | Jul 24, 2024 | — |
| 8-K |
Current report
Other events
|
Jul 18, 2024 | Jul 17, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 3, 2024 | Jun 27, 2024 |
| S-8 | Employee stock plan registration | Jul 1, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 1, 2024 | Jul 1, 2024 |
| 424B4 | Prospectus | Jun 28, 2024 | — |
| FWP | Free writing prospectus | Jun 28, 2024 | — |
| SEC STAFF LETTER | Filing | Jun 27, 2024 | — |
| EFFECT | Filing | Jun 27, 2024 | — |
| CERT | Filing | Jun 27, 2024 | — |
| 8-A12B | Form 8-a12b | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| S-1/A | Amended registration statement | Jun 24, 2024 | — |
| CORRESP | Letter to the SEC | Jun 18, 2024 | — |
| S-1/A | Amended registration statement | Jun 18, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2024 | — |
| SEC STAFF LETTER | Filing | Jun 14, 2024 | — |
| CORRESP | Letter to the SEC | Jun 14, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| S-1 | Registration statement | Jun 7, 2024 | — |
| UPLOAD | Letter from the SEC | May 30, 2024 | — |
| DRSLTR | Filing | May 15, 2024 | — |
| DRS/A | Filing | May 15, 2024 | — |
| UPLOAD | Letter from the SEC | May 8, 2024 | — |
| DRS | Filing | Apr 11, 2024 | — |
| D | Filing | Mar 11, 2024 | — |
| D | Filing | Mar 19, 2021 | — |
| D | Filing | Feb 25, 2021 | — |
Showing 113 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALMS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1847367
- Former names
- FL2021-001, Inc. (until Mar 19, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.